Biotech RadarJobs updated

COMPANY

Axogen

HQ: Alachua, FL source · axogeninc.com ↗ · Southeast

FDA-approved therapeutic company FDA-cleared device company Clinical Phase 3

42 open jobs · last seen Oct 23, 2026 · 15 sources

Location: Alachua, FL · source · Oct 14, 2026

Keywords: Peripheral Nerve Injury Symptomatic Neuroma Chronic Nerve Pain Peripheral Nerve Discontinuity Mixed Peripheral Nerve Injury Motor Peripheral Nerve Injury Upper Extremity Nerve Injury Amputation Peripheral Nerve Injuries Recurrent Cubital Tunnel Syndrome Recalcitrant Cubital Tunnel Syndrome Acute Upper Extremity Trauma Morton's Neuroma Prostate Cancer Radical Prostatectomy Nerve Reconstruction Cavernous Nerve Injury Chronic Neuropathic Pain Peripheral Nerve Discontinuities Traumatic Nerve Injury Avance Nerve Graft

Since the raise (Sep 10, 2026): 42 of 42 open jobs were first seen after it.

42Open jobs$332.7MRaised (2 yrs)10Trials (company is sponsor)1FDA records (2 yrs)1NIH grants

Hiring

TitleLocation (from posting)Employer postedFirst seen
Field Access & Reimbursement, Sr. Manager - Extremity/OMF Specialty (Western US)Tampa, Florida, United StatesOct 22, 2026Oct 23, 2026
Area Sales Manager - Toledo, OHToledo, Ohio, United StatesOct 19, 2026Oct 20, 2026
Clinical Research Associate II (Extremities Specialty)Tampa, Florida, United StatesOct 16, 2026Oct 17, 2026
Director, Enterprise Data & AI StrategyTampa, Florida, United StatesOct 15, 2026Oct 16, 2026
Area Sales Manager - Rochester/Upstate NYBuffalo, New York, United States; Rochester, New York, United States; Syracuse, New York, United StatesOct 15, 2026Oct 16, 2026

See all 42 jobs

Timeline

  1. Board tracked Radar started tracking this company’s job board (42 open jobs at last check). source ↗
  2. Raise Follow-on offering: $208.7M (total, as published), announced Sep 10, 2026. Source: company release on GlobeNewswire. source ↗
  3. Trial start Phase 4: Study Comparing Avance Nerve Graft and Autograft for Functional Recovery Following Mixed and Motor Peripheral Nerve Reconstruction source ↗
  4. Raise Follow-on offering: $124M (total, as published), announced Jan 22, 2026. Source: company release on GlobeNewswire. source ↗
  5. FDA FDA New drug/biologic (novel): avance nerve graft (acellular nerve allograft-arwx) — BLA125816, Dec 3, 2025. Applicant at approval: Axogen Corporation. Accelerated approval. source ↗
  6. Trial start Not phased (device or behavioral study): Nerve Protection Evaluation: Revision Cubital Tunnel Syndrome Decompression source ↗
  7. Trial start Not phased (device or behavioral study): Tolerability and Feasibility Pilot Clinical Study of a Large-Diameter Nerve Cap for Protecting and Preserving Terminated Nerve Ends source ↗
  8. Trial start —: Surgical Treatment of Chronic Neuropathic Pain source ↗
  9. Trial start —: Registry of Avive® Soft Tissue Membrane Utilization in Selected Applications of Acute Trauma of the Upper Extremity source ↗
  10. Trial start Not phased (device or behavioral study): Study of AxoGuard® Nerve Cap and Neurectomy for Treatment of Symptomatic Neuroma & Prevention of Recurrent Neuroma Pain source ↗
  11. Trial start Phase 3: Comparison of Processed Nerve Allograft and Collagen Nerve Cuffs for Peripheral Nerve Repair source ↗
  12. Trial start Phase 4: Study of Nerve Reconstruction Using AVANCE in Subjects Who Undergo Robotic Assisted Prostatectomy for Treatment of Prostate Cancer source ↗
  13. Trial start Not phased (device or behavioral study): A Comparative Post-marketing Study of Commercially Available Peripheral Nerve Gap Repair Options source ↗
  14. Trial start —: Registry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Open jobs 42

TitleLocation (from posting, not HQ)Employer postedFirst seenLevel
Field Access & Reimbursement, Sr. Manager - Extremity/OMF Specialty (Western US)Tampa, Florida, United StatesOct 22, 2026Oct 23, 2026Not stated
Area Sales Manager - Toledo, OHToledo, Ohio, United StatesOct 19, 2026Oct 20, 2026Not stated
Clinical Research Associate II (Extremities Specialty)Tampa, Florida, United StatesOct 16, 2026Oct 17, 2026Not stated
Director, Enterprise Data & AI StrategyTampa, Florida, United StatesOct 15, 2026Oct 16, 2026Not stated
Area Sales Manager - Rochester/Upstate NYBuffalo, New York, United States; Rochester, New York, United States; Syracuse, New York, United StatesOct 15, 2026Oct 16, 2026Not stated
Supervisor, Operations (Tissue Processing) - 3rd shiftVandalia, Ohio, United StatesOct 14, 2026Oct 15, 2026Senior
Sr. Clinical Research Associate (Breast Specialty)Tampa, Florida, United StatesOct 14, 2026Oct 15, 2026Senior
Area Sales Manager - Denver, CODenver, Colorado, United StatesOct 13, 2026Oct 14, 2026Mid
Processing Technician- 2nd shiftVandalia, Ohio, United StatesOct 8, 2026Oct 9, 2026Entry
Sr. Construction EngineerVandalia, Ohio, United StatesOct 6, 2026Oct 9, 2026Senior
Supervisor, Operations (Warehouse & Materials) - 2nd shiftVandalia, Ohio, United StatesOct 6, 2026Oct 9, 2026Senior
Supervisor, Operations (Cleaning & Sterilization) - 3rd shiftVandalia, Ohio, United StatesOct 5, 2026Oct 9, 2026Senior
Supervisor, Operations (Cleaning & Sterilization) - 2nd shiftVandalia, Ohio, United StatesOct 5, 2026Oct 9, 2026Senior
Supervisor, Operations (Cleaning & Sterilization) - 1st shiftVandalia, Ohio, United StatesOct 5, 2026Oct 9, 2026Senior
Intern - Legal (Spring 2027)Tampa, Florida, United StatesOct 5, 2026Oct 9, 2026Entry
Processing Technician- 1st shiftVandalia, Ohio, United StatesOct 5, 2026Oct 9, 2026Entry
Cleaning & Sterilization Technician - 3rd shiftVandalia, Ohio, United StatesOct 5, 2026Oct 9, 2026Entry
Material Control Technician- 3rd shiftVandalia, Ohio, United StatesOct 1, 2026Oct 9, 2026Entry
Material Control Technician- 2nd shiftVandalia, Ohio, United StatesOct 1, 2026Oct 9, 2026Entry
Material Control Technician- 1st shiftVandalia, Ohio, United StatesOct 1, 2026Oct 9, 2026Entry
Clinical Research Associate II (Breast Specialty)Tampa, Florida, United StatesSep 29, 2026Oct 9, 2026Mid
Sales Representative - Salt Lake City, UTSalt Lake City, UTSep 29, 2026Oct 9, 2026Entry
Breast Reconstruction Specialist - San Francisco, CASan Francisco, California, United StatesSep 29, 2026Oct 9, 2026Mid
Accounts Payable SpecialistTampa, Florida, United StatesSep 22, 2026Oct 9, 2026Mid
Manager, IT Operations(Biologics)Vandalia, Ohio, United StatesSep 21, 2026Oct 9, 2026Senior
Associate Program ManagerVandalia, Ohio, United StatesSep 11, 2026Oct 9, 2026Mid
Cleaning & Sterilization Technician - 2nd shiftVandalia, Ohio, United StatesSep 1, 2026Oct 9, 2026Entry
Manager, Quality AssuranceVandalia, Ohio, United StatesSep 1, 2026Oct 9, 2026Senior
Processing Tech (3rd shift openings asap)Vandalia, Ohio, United StatesAug 31, 2026Oct 9, 2026Entry
Sr. Engineer, QualityVandalia, Ohio, United StatesAug 31, 2026Oct 9, 2026Senior
Sr. Engineer, Supplier QualityVandalia, Ohio, United StatesAug 28, 2026Oct 9, 2026Senior
Engineer II, Manufacturing & ProcessingVandalia, Ohio, United StatesAug 28, 2026Oct 9, 2026Mid
Technician Talent Community | Vandalia, OH Processing CenterVandalia, Ohio, United StatesAug 28, 2026Oct 9, 2026Not stated
Facilities Maintenance TechnicianVandalia, Ohio, United StatesAug 27, 2026Oct 9, 2026Entry
Quality Analyst - 3rd shiftVandalia, Ohio, United StatesAug 25, 2026Oct 9, 2026Entry
Area Sales Manager - Chicago SouthChicago, Illinois, United StatesAug 14, 2026Oct 9, 2026Mid
Sr. Engineer, R&D (Biomaterials)Tampa, Florida, United StatesJul 24, 2026Oct 9, 2026Senior
Director, Market Development (Head & Neck Specialty)Tampa, Florida, United States; WFH/RemoteJun 29, 2026Oct 9, 2026Senior
Area Sales Manager - Bronx, NYNew York, United StatesJun 17, 2026Oct 9, 2026Mid
Field Sales Talent Community | US - All LocationsTampa, Florida, United StatesAug 11, 2021Oct 9, 2026Not stated
Intern Talent Community | Tampa, FLTampa, Florida, United StatesAug 11, 2021Oct 9, 2026Not stated
Corporate Talent Community | Tampa, FL & Alachua, FLTampa, Florida, United StatesSep 23, 2019Oct 9, 2026Not stated

Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.

Funding

Raised: $332.7M. Last 2 years.

Clinical trials (lead sponsor) 10

RecordTitlePhaseStatusStartPrimary completion
NCT07657182Study Comparing Avance Nerve Graft and Autograft for Functional Recovery Following Mixed and Motor Peripheral Nerve ReconstructionPhase 4RecruitingJun 11, 2026Dec 5, 2030 (estimated)
NCT04865679Tolerability and Feasibility Pilot Clinical Study of a Large-Diameter Nerve Cap for Protecting and Preserving Terminated Nerve EndsNot phased (device or behavioral study)Active, not recruitingMar 2, 20222026-12 (estimated)
NCT01526681Registry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve ReconstructionNot listedActive, not recruiting2008-112028-11 (estimated)
NCT06117501Nerve Protection Evaluation: Revision Cubital Tunnel Syndrome DecompressionNot phased (device or behavioral study)Active, not recruitingOct 19, 20232026-12 (estimated)
NCT03943134Registry of Avive® Soft Tissue Membrane Utilization in Selected Applications of Acute Trauma of the Upper ExtremityNot listedTerminatedDec 1, 2018Dec 17, 2020 (actual)
NCT03940963Study of AxoGuard® Nerve Cap and Neurectomy for Treatment of Symptomatic Neuroma & Prevention of Recurrent Neuroma PainNot phased (device or behavioral study)CompletedOct 10, 2018Jul 17, 2023 (actual)
NCT00953277Study of Nerve Reconstruction Using AVANCE in Subjects Who Undergo Robotic Assisted Prostatectomy for Treatment of Prostate CancerPhase 4Completed2009-082015-04 (actual)
NCT04287075Surgical Treatment of Chronic Neuropathic PainNot listedTerminatedFeb 19, 2020Jan 24, 2024 (actual)
NCT01809002Comparison of Processed Nerve Allograft and Collagen Nerve Cuffs for Peripheral Nerve RepairPhase 3Completed2015-06Aug 30, 2021 (actual)
NCT00948025A Comparative Post-marketing Study of Commercially Available Peripheral Nerve Gap Repair OptionsNot phased (device or behavioral study)Terminated2009-062014-12 (actual)

FDA records (last 2 years)

NIH awards 1

Annual award amounts. Total $103K.

Connect

See your connections at Axogen on LinkedIn (search by name, results not checked)

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-12

Feedback